Faktor resiko contrast induced nephropathy pada pasien yang menjalani prosedur coronary intervention
DOI:
https://doi.org/10.36216/jpd.v5i1.148Keywords:
risk, CIN, AKI, coronary interventionAbstract
Background: Contrast-induced nephropathy (CIN) is a manifestation of acute kidney injury (AKI) that occurs after exposure to intravascular contrast media. This often occurs after cardiac catheterization or percutaneous coronary intervention (PCI). So it is important to know what risk factors can affect the occurrence of CIN in patients undergoing coronary intervention.
Objective: To determine the relationship of CIN risk factors to the incidence of CIN in patients undergoing coronary intervention.
Methods: Prospective cohort study of 50 patients undergoing coronary intervention at Sanglah Hospital in January - June 2019. Analysis bivariate using the chi square, if the condition is not fulfilled, analyze using Fisher test. Then, multivariate analysis with logistic regression was performed. Data analysis using SPSS software version 24.0.
Result: Of the 50 patients who underwent coronary intervention as many as 7 people experienced CIN. Risk factors that were statistically significant related to the incidence of CIN, including serum creatinin levels before treatment (RR, 1,53; 95% CI, 1,11-2,12; p = 0,001), and amount of contrast (RR, 6,074; 95% CI, 1,64-22,54; p = 0,015). Multivariate analysis with probability of CIN in patients with contrast ≥ 100 ml and serum creatinine> 1.5 (p = 66%).
Conclusion: there was a statistically significant relationship between serum creatinin levels and the amount of contrast with the incidence of CIN in patients undergoing coronary intervention.
Downloads
References
Pakfetrat M, Nikoo MH, Malekmakan L, dkk. Risk factors for contrast-related acute kidney injury according to risk, injury, failure, loss, and end-stage criteria in patients with coronary interventions. Iranian journal of kidney diseases. 2010;4(2):116.
Sany D, Refaat H, Elshahawy Y, dkk. Frequency and risk factors of contrast-induced nephropathy after cardiac catheterization in type II diabetic patients: a study among Egyptian patients. Renal failure. 2014;36(2):191-197.
Brown JR, MacKenzie TA, Maddox TM, dkk. Acute kidney injury risk prediction in patients undergoing coronary angiography in a national Veterans Health Administration cohort with external validation. Journal of the American Heart Association. 2015;4(12):e002136.
Solomon R. Contrast-induced acute kidney injury: is there a risk after intravenous contrast?. Clin J Am Soc Nephrol; 2008;3(5):1242-1243.
Mehran R, Aymong ED, Nikolsky E, dkk. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. Journal of the American College of Cardiology. 2004;44(7):1393-1939.
Abellás-Sequeiros R, Raposeiras-Roubín S, Abu-Assi E, dkk. Mehran contrast nephropathy risk score: is it still useful 10 years later?. Journal of cardiology. 2016;67(3):262-267.
Bhatt S, Rajpal N, Rathi V, dkk. Contrast induced nephropathy with intravenous iodinated contrast media in routine diagnostic imaging: an initial experience in a tertiary care hospital. Radiol Res Pract. 2016;2016:8792984.
Budijanto D, Pusdatin–Kemenkes R. Populasi, Sampling, dan Besar Sampel. Kementerian Kesehatan RI. 2013.
Parlindungan HW. Tesis: Nilai Skor CHA2DS2-VASC-HSF Sebagai Prediktor Kejadian Nefropati yang Diinduksi Kontras pada Pasien Sindroma Koroner Akut yang Menjalani Prosedur Intervensi Koroner Perkutan. Universitas Sumatera Utara. 2017 [Diunduh dari: https://repositori.usu.ac.id/bitstream/handle/123456789/5159/137115006.pdf?sequence=1&isAllowed=y]
Takaya Y, Yoshihara F, Yokoyama H, dkk. Risk stratification of acute kidney injury using the blood urea nitrogen/creatinine ratio in patients with acute decompensated heart failure. Circulation Journal. 2015;79(7):1520-1525.
Liu Y, Liu Y-h, Chen J-y, dkk. Safe contrast volumes for preventing contrast-induced nephropathy in elderly patients with relatively normal renal function during percutaneous coronary intervention. Medicine. 2015;94(12):e615.
Khatami MR, Nikravan N, Salari-Far M, dkk. A comparison of definitions of contrast-induced nephropathy in patients with normal serum creatinine. Saudi Journal of Kidney Diseases and Transplantation. 2016;27(1):94.
Davenport MS, Khalatbari S, Cohan RH, dkk. Contrast material–induced nephrotoxicity and intravenous low-osmolality iodinated contrast material: risk stratification by using estimated glomerular filtration rate. Radiology. 2013;268(3):719-728.
Meinel FG, De Cecco CN, Schoepf UJ, dkk. Contrast-induced acute kidney injury: definition, epidemiology, and outcome. Biomed Res Int. 2014;2014:859328.
Mehran R, Nikolsky E. Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney international. 2006;69:S11-S5.
Wacker-Gußmann A, Bühren K, Schultheiss C, dkk. Prediction of contrast-induced nephropathy in patients with serum creatinine levels in the upper normal range by cystatin C: a prospective study in 374 patients. American Journal of Roentgenology. 2014;202(2):452-458.
Ayu NP. Perubahan Kadar Kreatinin Serum Pasca Paparan Media Kontras Pada Tindakan Intervensi Kardiologi. Denpasar: Universitas Udayana; 2018.
Goldfarb S, McCullough PA, McDermott J, Gay SB, editors. Contrast-induced acute kidney injury: specialty-specific protocols for interventional radiology, diagnostic computed tomography radiology, and interventional cardiology. Mayo Clinic Proceedings; 2009: Elsevier.
Marenzi G, Assanelli E, Campodonico J, dkk. Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality. Annals of internal medicine. 2009;150(3):170-177.
Kagan A, Sheikh‐Hamad D. Contrast‐induced kidney injury: focus on modifiable risk factors and prophylactic strategies. Clinical cardiology. 2010;33(2):62-66.
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Jurnal Penyakit Dalam Udayana
This work is licensed under a Creative Commons Attribution 4.0 International License.